Veracyte

ISIN US92337F1075

WKN A1W7EA

Marktkapitalisatie (in EUR)

2.558 m

Land

Verenigde Staten

Sector

Gezondheidszorg

Dividendrendement

0,00%

|Transfer your stocks & ETFs or start investing and get 1% from Bitpanda – only until 14 February. T&C's apply* Learn more

Overview

Quote

Description

Veracyte, Inc. houdt zich bezig met onderzoek, ontwikkeling en verkoop van diagnostische producten. De portfolio van het bedrijf omvat Afirma, Percepta en Envisia. Het bedrijf wil schildklierkanker behandelen, de screening op longkanker verbeteren en de diagnose van idiopathische longfibrose verduidelijken. Het bedrijf werd op 15 augustus 2006 opgericht door Bonnie H. Anderson en Y. Douglas Dolginow en het hoofdkantoor is gevestigd in South San Francisco, CA.

Show more Show less

Gezondheidszorg Gezondheidszorgapparatuur Diagnostiek en Medicijnafgifte Hulpmiddelen Verenigde Staten

Chart

Financials

Key metrics

Market capitalisation, EUR	2.558 m
EPS, EUR	0,34
P/B ratio	2,4
P/E ratio	100,5
Dividend yield	0,00%

Winst- en verliesrekening (2024)

Revenue, EUR	412 m
Net income, EUR	22 m
Profit margin	5,41%

In welke ETF zit Veracyte?

Er zijn 6 ETF's die Veracyte bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Veracyte is de Global X Telemedicine & Digital Health UCITS ETF Acc USD.

ETF	Weight	Investment focus	Fund size (in m EUR)
Global X Telemedicine & Digital Health UCITS ETF Acc USD	5,23%	Aandelen Wereld Gezondheidszorg	5
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0,30%	Aandelen Verenigde Staten Gezondheidszorg Biotech	46
iShares S&P SmallCap 600 UCITS ETF	0,22%	Aandelen Verenigde Staten Small Cap	1.920
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0,00%	Aandelen Wereld Sociaal/Milieu	490
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0,01%	Aandelen Noord-Amerika Sociaal/Milieu	25
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0,06%	Aandelen Verenigde Staten Small Cap	187

Performance

Returns overview

YTD	-14.89%
1 month	-11.60%
3 months	+0.63%
6 months	+55.34%
1 year	-26.77%
3 years	+29.55%
5 years	-
Since inception (MAX)	-26.94%
2025	-1.31%
2024	+47.10%
2023	+14.30%
2022	-34.13%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).